Filter
8788
Filtered Results: 8788
Text search:
patient
information
Featured
Recommendations
852
New Publications
2202
Language
Document type
No document type
4872
Studies & Reports
1250
Guidelines
1228
Manuals
463
Strategic & Response Plan
284
Fact sheets
259
Training Material
171
Situation Updates
107
Resource Platforms
47
Brochures
42
Infographics
37
Online Courses
19
Videos
8
App
1
Countries / Regions
India
430
Global
294
Kenya
231
South Africa
224
Sierra Leone
209
Liberia
186
Western and Central Europe
172
Ethiopia
167
Nigeria
160
Uganda
154
Congo, Democratic Republic of
151
Africa
129
Malawi
118
Tanzania
117
Rwanda
112
Nepal
110
Latin America and the Carribbean
106
Senegal
101
Zambia
100
Myanmar / Burma
94
Ghana
93
Bangladesh
92
Germany
83
Syria
83
Guinea
82
Burkina Faso
78
Haiti
77
Ukraine
76
Namibia
63
Eastern Europe
61
West and Central Africa
60
Benin
58
Philippines
57
Cambodia
52
Mozambique
50
East and Southern Africa
50
South–East Asia Region
50
Zimbabwe
47
South Sudan
47
Cameroon
46
Lesotho
46
Russia
44
Asia
42
Middle East and North Africa
41
Brazil
39
Mali
37
Madagascar
37
Indonesia
34
Botswana
32
Eastern Europe and Central Asia
30
Côte d’Ivoire / Ivory Coast
25
Central African Republic
25
Yemen
23
Venezuela
23
USA
21
Eswatini/ Swaziland
21
Colombia
19
Niger
17
Togo
15
Pakistan
15
Western Pacific Region
15
Tajikistan
15
Peru
14
Somalia
13
Afghanistan
13
Chad
13
Angola
13
Thailand
12
Sudan
12
Vietnam
12
Iraq
11
Lebanon
11
Albania
11
Georgia
11
Sri Lanka
10
Laos
10
Jordan
9
China
9
Bolivia
9
Moldova
9
United Kingdom
9
Argentina
8
Ecuador
8
Chile
8
Palestine
8
Southern Africa
8
Burundi
7
North America
7
Spain
7
Guinea-Bissau
6
Turkey
6
North Macedonia
6
Switzerland
6
Mexico
6
France
6
Morocco
5
Paraguay
5
Armenia
5
Canada
5
Jamaica
5
Gambia
4
Hungary
4
Bhutan
4
Poland
4
Congo-Brazzaville
4
Kyrgyzstan
4
Kazakhstan
4
Ireland
3
Papua New Guinea
3
Serbia
3
Honduras
3
El Salvador
3
Greece
3
Libya
3
Italy
3
Timor Leste/ East Timor
3
Romania
3
Uzbekistan
3
Saudi Arabia
2
Malaysia
2
Singapore
2
Guatemala
2
Fiji
2
Bulgaria
2
Estonia
2
Lithuania
2
Slovakia
2
Iran
2
Australia
2
Gabon
2
Belgium
2
Mauritius
2
Tunisia
2
Portugal
2
Egypt
1
Mauritania
1
Austria
1
Nicaragua
1
Other region
1
Luxembourg
1
Solomon Islands
1
North Korea
1
Djibouti
1
Mongolia
1
Qatar
1
Turkmenistan
1
Japan
1
Denmark
1
Maldives
1
Norway
1
South Korea
1
Belarus
1
French Guyana
1
Israel
1
Latvia
1
United Arab Emirates
1
Authors & Publishers
Publication Years
Category
Countries
3248
Clinical Guidelines
783
Public Health
466
Women & Child Health
367
Key Resources
274
Capacity Building
197
Pharmacy & Technologies
117
Annual Report MEDBOX
2
Toolboxes
COVID-19
962
Mental Health
706
HIV
648
TB
561
Ebola
417
Caregiver
319
Rapid Response
311
AMR
300
NTDs
233
Pharmacy
201
Refugee
193
NCDs
186
Conflict
176
Disability
171
Planetary Health
133
Global Health Education
86
Cholera
80
Zika
66
Natural Hazards
64
Specific Hazards
53
Polio
44
Health Financing Toolbox
38
Social Ethics
29
Typhoon
3
South Sudan
1
Health Financing
1
Event-based surveillance (EBS) is defined as the organized collection, monitoring, assessment and interpretation of mainly unstructured ad hoc information regarding health events or risks, which may represent an acute risk to health. Both indicator-...
Health workers involved in deployment and implementation of COVID-19 vaccination require vaccine-specific knowledge to ensure safe and efficient vaccine delivery. This training provides key information about COVID-19 vaccines through short instructi...
22 April 2022, This document provides updated interim recommendations on the use of masks by health workers providing care to patients with suspected or confirmed COVID-19. This update is prompted by new evidence around mask use and COVID-19 transmi...
To test for ethnic discrimination in access to outpatient health care services, we carry out
an email-correspondence study in Germany. We approach 3,224 physician offices in the 79
largest cities in Germany with fictitious appointment requests and randomized ...’
characteristics. We find that patients’ ethnicity, as signaled by distinct Turkish versus Ger-
man names, does not affect whether they receive an appointment or wait time. In contrast,
patients with private insurance are 31 percent more likely to receive an appointment. Hold-
ing a private insurance also increases the likelihood of receiving a response and reduces the
wait time. This suggests that physicians use leeway to prioritize privately insured patients
to enhance their earnings, but they do not discriminate persons of Turkish origin based
on taste. Still, their behavior creates means-based barriers for economically disadvantaged
groups.
During the COVID-19 health crisis, community pharmacists had an enhanced role in supporting health-care systems that were overburdened by managing seriously ill patients. This study was undertaken to determine the patterns of community supply of ant...
Interim rapid response guidance, 10 June 2022.
It includes considerations for certain populations such as patients with mild disease with considerations for community care, patients with moderate t...
Interim rapid response guidance, 10 June 2022.
It includes considerations for certain populations such as patients with mild disease with considerations for community care, patients with moderate t...
Guidance for health care workers.
Both the REGN-EB3 and mAb114 are recommended for use in EVD. The two drugs should not be given together. The choice of which monoclonal antibody to use depends on availability, including emerging information about...
Cocktail d’anticorps monoclonaux neutralisant REGN-EB3 contre la maladie à virus Ebola (MVE)
recommended
Guidance for health care workers.
Both the REGN-EB3 and mAb114 are recommended for use in EVD. The two drugs should not be given together. The choice of which monoclonal antibody to use depends on availability, including emerging information about...
Therapeutics for Ebola virus disease
recommended
The WHO Ebola Virus Disease (EVD) Clinical management: living guidance contains the Organization’s most up-to-date recommendations for the clinical management of people with EVD. Providing guidance that is comprehensive and holistic for the optimal care of ... with EVD throughout their illness is important.
The living guidance is available in both pdf format (via the ‘Download’ button) and via an online platform in both French and English, and is updated regularly as new evidence emerges.
This first version of the Clinical management for EVD living guidance contains four new recommendations regarding use of therapeutics for EVD, this includes two strong recommendations for the use of monoclonal antibody therapies. This new living guideline is written to accompany the optimized supportive care (oSoC) for EVD standard operating procedures (5, 6). The living guideline aims to summarize high quality evidence for EVD therapeutics and make recommendations for their use.
Addressing comorbidities and risk factors for TB is a crucial component of Pillar one of the End TB Strategy, which focuses on integrated patient-centred care and prevention, including action on TB and comorbidities. The Framework for collaborative ...
Buruli ulcer : management of Mycobacterium ulcerans disease : a manual for health care providers
recommended
This manual is addressed to health care providers dealing with Mycobacterium ulcerans disease (Buruli ulcer). The manual aims to achieve a better understanding of the disease, its clinical presentation and its surgical management. The manual is aimed particularly at district health care providers. A...
Buruli ulcer caused by Mycobacterium ulcerans is a neglected tropical disease characterized by extensive ulceration involving predominantly the upper and lower limbs of patients. The disease is common in rural tropical communities in West and Centra...
The socioeconomic factors and public health inadequacies that facilitated the rapid spread of this infection continue to exist. As it is a new and emerging disease it has not received sufficient coverage yet in the medical curricula of Member States. Specific treatment is not available, and there is...
Abstract: Chagas disease is caused by infection with the protozoan Trypanosoma cruzi, and although over 100 years have passed since the discovery of Chagas disease, it still presents an increasing problem for global public health. A plethora of information... concerning the chronic phase of human Chagas disease, particularly the severe cardiac form, is available in the literature. However, information concerning events during the acute phase of the disease is scarce. In this review, we will discuss the current status of acute Chagas disease cases globally, the immunological findings related to the acute phase and their possible influence in disease outcome, and reactivation of Chagas disease in immunocompromised individuals, a key point for transplantation and HIV invection management.
Mem Inst Oswaldo Cruz, Rio de Janeiro, Vol. 117: e200460, 2022
Integrating the multiple dimensions of the problem into a coherent approach adapted to field realities and needs represents an immense challenge, but the payoff is more effective and sustainable experiences, with higher social awareness...
This was a Phase 3, multi-center, randomized, open-label, parallel-group, active control study where 273 male and female patients with first stage Trypanosoma brucei gambiense HAT were treated at six sites: one trypanosomiasis reference center in An...
Arsenical monotherapies were previously very successful for treating human African trypanosomiasis (HAT).
Melarsoprol resistance emerged as early as the 1970s and was widespread by the late 1990s.
Melarsoprol resistance represents the only example of widespread drug resistance in HAT ... where the genetic mechanism has been established.
The current goal of elimination of HAT as a public health problem by 2020 may be undermined by the emergence and spread of resistance to current or new drugs.
Insights into potential resistance mechanisms for current and new drugs will facilitate predictions of the likelihood of resistance and will also facilitate rational approaches to minimizing, monitoring, and tackling the future emergence of resistance.
Background: One of the objectives of the Global Action Plan by the World Health Organization (WHO) to contain antimicrobial resistance (AMR), is to improve global awareness through effective communication and education. Comprehensive information on ...
I examine the effectiveness of donors in targeting the highest burden of malaria in the Democratic Republic of Congo when health information structure is fragmented. I exploit local variations in the burden of malaria induced by mining activities as...
